Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Valproate and Risperidone in Young Children With Bipolar Disorders
NCT00221403Phase 3Completed
- Sponsor
- Cincinnati Children's Hospital Medical Center
- Start
- Sep 2004
- Primary completion
- May 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in bipolar disorder (BD) comparing Valproate (VPA), Risperidone and Placebo (3 arms). Primary endpoint: Young Mania Rating Scale at 6 weeks. Started Sep 2004; status: completed.
02
Drugs
valproic acidrisperidone
03
Conditions
bipolar disorder (BD)
Beyond the preview
Go deeper on NCT00221403.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00221403.